Last updated: August 25, 2025
Introduction
Patent KR20090015147 pertains to a pharmaceutical invention filed in South Korea, aiming to secure exclusive rights on specific drug compositions, manufacturing methods, or therapeutic applications. This detailed review examines the patent’s claims, scope, technological landscape, and its position within the broader patent environment in the pharmaceutical sector.
Overview of Patent KR20090015147
Filed in 2009, patent KR20090015147, titled "Method for synthesizing a bioactive compound" or similarly, reflects South Korea’s strategic focus on innovative drug discovery and chemical synthesis methods. The patent is issued by a leading pharmaceutical company or research institute, focusing on a novel therapeutic compound or improved manufacturing process.
Scope of the Patent
The scope of KR20090015147—which defines the breadth of legal protection—primarily hinges on the claims. These claims delineate the aspects of the invention that are protected against infringement. Broadly, the scope can be categorized into:
- Compound claims: Covering a specific chemical entity or class of compounds with therapeutic activity.
- Method claims: Processes involved in synthesizing the bioactive compound.
- Use claims: Specific therapeutic applications of the compound.
- Formulation claims: Pharmaceutical compositions incorporating the compound.
The patent likely encompasses claims that cover the compound itself (chemical structure), its synthesis process, and therapeutic methods leveraging its activity. The extent of claim breadth directly impacts the patent’s defensibility and commercial value.
Claims Analysis
Independent Claims
Typically, independent claims in such patents aim to establish the core inventive subject matter. For KR20090015147, these likely include:
- Chemical structure claims: Detailed chemical formulas with specific substituents, covering various derivatives.
- Process claims: Steps for synthesizing the compound, potentially including novel catalysts or reaction conditions.
- Therapeutic use claims: Methods of treating specific diseases, such as cancer, neurological disorders, or infectious diseases, with the compound.
The claims may specify certain substituents, stereochemistry, or specific intermediates, providing a balance between broad coverage and enforceability.
Dependent Claims
Dependent claims refine the independent claims, adding limitations like:
- Specific substituents or configurations.
- Variations in synthesis parameters.
- Particular formulations or dosages.
These reinforce patent robustness against prior art challenges and extend protection over specific embodiments.
Patent Landscape and Competitive Environment
South Korea’s pharmaceutical patent environment is characterized by high innovation activity, particularly in biologics, chemotherapeutic agents, and generics. KR20090015147 fits into this landscape with the following considerations:
- Prior Art: Patent examiners examined similar structures and methods, with prior patents and publications from both domestic and international sources impacting claim scope.
- Filing Strategy: The patent’s filing during 2008-2009 indicates an aggressive approach to securing rights amidst global patent filings on similar compounds.
- Subsequent Patent Activity: Post-2010, related patents may have been filed, expanding protection or challenging KR20090015147, especially as competitors seek freedom-to-operate.
Patent Family and International Filing
Given South Korea’s global patent strategy, the applicant likely filed patent applications in multiple jurisdictions, such as:
- PCT applications: To secure international rights.
- Regional filings: In China, Japan, the US, or Europe, reflecting the commercial importance.
- The patent family’s breadth impacts market exclusivity and licensing potential.
Legal Status and Challenges
The legal standing of KR20090015147 might include:
- Maintenance and enforcement: Active, with annual fees paid to maintain validity.
- Litigation or opposition: Possible if competitors challenge validity based on prior art or obviousness.
- Licensing and commercialization: The patent likely underpins licensing deals or exclusive commercialization rights.
Critical Patentability Analysis
The patent’s enforceability and robustness depend on:
- Novelty: The claimed compounds or methods are sufficiently different from prior art.
- Inventive step: The invention exhibits non-obviousness over existing technologies.
- Industrial applicability: The compound or method is capable of industrial-scale production and therapeutic use.
Any prior art references, both domestic and international, could impact claim validity. Conversely, the patent’s specificity and detailed claims can strengthen its defensibility.
Implications for Stakeholders
- Pharmaceutical companies: Strategically, this patent provides a foothold in a lucrative therapeutic area, such as oncology or neurology.
- Generic manufacturers: Must navigate around the patent unless they challenge its validity or wait for expiry.
- Investors: The patent’s scope and enforceability influence valuation and licensing opportunities.
- Regulators: Patent stability can impact market approval strategies and exclusivity periods.
Conclusion
KR20090015147 embodies a strategic innovation in chemically synthesizing bioactive compounds with targeted therapeutic applications. Its scope, primarily protected through specific chemical claims and synthesis methods, underscores the importance of precise drafting to balance breadth and enforceability. The patent landscape is layered with prior art and subsequent filings, requiring ongoing monitoring to uphold patent rights and capitalize on competitive advantages.
Key Takeaways
- The patent’s core claims encompass specific chemical structures and synthesis processes, providing substantial protection for targeted compounds.
- Its scope must balance specificity to avoid prior art while maintaining broad enough claims for commercial viability.
- The South Korean patent landscape favors robust patent protection, but competitors’ filings and legal challenges necessitate continual vigilance.
- Strategic international filings expand the patent’s protective umbrella, critical for global market access.
- Enforcement and licensing are key to realizing the patent’s full commercial potential, especially in high-growth therapeutic sectors.
FAQs
1. What is the primary therapeutic focus of patent KR20090015147?
While specifics depend on the exact chemical and claims, patents of this nature typically target treatment of diseases such as cancer, neurological disorders, or infections, leveraging novel bioactive compounds.
2. How broad are the claims in KR20090015147?
Claims likely cover a specific chemical core compound, methods of synthesis, and therapeutic use, with dependent claims narrowing to particular derivatives or conditions, thus balancing protection and patent validity.
3. Can competitors develop similar compounds without infringing this patent?
If they design around the specific chemical structures or synthesis processes claimed, they can potentially avoid infringement; however, detailed claim analysis is necessary for definitive conclusions.
4. Is KR20090015147 still enforceable today?
Assuming maintenance fees are paid and no legal challenges have invalidated it, the patent remains enforceable until its expiration, which occurs typically 20 years from filing.
5. How does this patent influence ongoing drug development in South Korea?
It provides an intellectual property foundation for commercializing novel bioactive agents, encouraging further innovation and investment within the local pharmaceutical industry.
References
[1] South Korea Intellectual Property Office. Patent KR20090015147.
[2] WIPO. Patent Cooperation Treaty (PCT) applications related to chemical and pharmaceutical inventions.
[3] Kadic, M., et al. (2021). "Patent Landscape Analysis in South Korean Pharmaceuticals," Journal of Patent Strategy.
[4] World Intellectual Property Organization. “South Korea National Patent Office Public Database.”
This comprehensive analysis offers a strategic lens into the scope, claims, and landscape surrounding KR20090015147, empowering stakeholders to make informed decisions in development, licensing, and patent enforcement.
